CAV1 and acute respiratory distress syndrome: A recent study demonstrated that pravastatin ameliorates sepsis-induced ALI, improves the alveolar endothelial barrier, and inhibits apoptosis in pulmonary parenchyma through regulating the caveolin-1/eNOS signaling pathway [18].